Daniel R. Omstead
President at abrdn Life Sciences Investors
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: abrdn Healthcare Investors, 3 years.
abrdn Healthcare Investors
Director · President
abrdn Life Sciences Investors
Director · President
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 25, 2023 | abrdn Life Sciences Investors | Open-market purchase | +10,096 | $12.39 | $125,089 |
| Sep 25, 2023 | abrdn Healthcare Investors | Open-market purchase | +9,500 | $15.63 | $148,485 |
| Sep 20, 2023 | abrdn Life Sciences Investors | Open-market purchase | +12,000 | $12.68 | $152,160 |
| Sep 20, 2023 | abrdn Healthcare Investors | Open-market purchase | +9,500 | $15.88 | $150,860 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.